section name header

Pronunciation ⬇

sye-kloe-PEER-ox

Classifications ⬆ ⬇

Therapeutic Classification: antifungals (topical)

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Inhibits the transport of essential elements in fungal cell, disrupting the synthesis of DNA, RNA, and protein.
Therapeutic effects:
  • Decrease in symptoms of fungal infection.

Pharmacokinetics ⬆ ⬇

Absorption: Absorption through intact skin is minimal (<5%).

Distribution: Distribution after topical administration is primarily local.

Metabolism/Excretion: Eliminated by kidneys (3–10% for gel).

Half-Life: 5.5 hr (gel).

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
Topunknownunknownunknown



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Local: burning, itching, local hypersensitivity reactions, redness, stinging

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Ciclodan, Loprox, Penlac

Canadian Brand Names ⬆

Stieprox